Furthermore, patients with mild cognitive impairment (MCI) have been identified to be at a greater risk of AD development due to a decrease of anti-inflammatory TGF-β and increased production of proinflammatory TNFα (37). Here, TGFB1 is linked to Alzheimer disease.